PharmGen Science Market Cap

PharmGen Science has a market cap or net worth of 77.27 billion as of June 27, 2025. Its market cap has decreased by -22.96% in one year.

Market Cap

77.27B

Enterprise Value

82.61B

Revenue

171.66B

Ranking

n/a

PE Ratio

656.21

Stock Price

4,325.00

Market Cap Chart

Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 77.27B, an increase of 609.41%. That is a compound annual growth rate of 6.79%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	80.90B	9.06%
Dec 30, 2024	74.18B	-33.39%
Dec 28, 2023	111.36B	5.58%
Dec 29, 2022	105.47B	-33.88%
Dec 30, 2021	159.51B	-3.78%
Dec 30, 2020	165.78B	123.51%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.46T
Celltrion	35.49T
ALTEOGEN	20.84T
Yuhan	7,589.05B
SK Biopharmaceuticals	7,236.14B
HLB Co., Ltd.	6,512.41B
PharmaResearch	4,992.23B
Peptron	4,741.01B

Market Cap Rankings